| NCT ID | NCT07615686 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bailey Petersen |
| Condition | Spina Bifida |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-06-10 |
| Primary Completion | 2028-03-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-06-10 with a primary completion date of 2028-03-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Eligibility Criteria
Inclusion Criteria: * Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist * Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance. * Between the ages of 4 and 17 years of age. * Documented neurogenic bladder dysfunction * On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial Exclusion Criteria: * Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator. * Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months. * Is pregnant. Pregnancy will be assessed via verbal report. * Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation. * Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps) * Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.
Contact & Investigator
Bailey Petersen, PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT07615686 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 17 Years, studying Spina Bifida. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07615686 currently recruiting?
Yes, NCT07615686 is actively recruiting participants. Contact the research team at syb17@pitt.edu for enrollment information.
Where is the NCT07615686 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07615686 clinical trial?
NCT07615686 is sponsored by Bailey Petersen. The principal investigator is Bailey Petersen, PhD at University of Pittsburgh. The trial plans to enroll 20 participants.